Ajay K. Gopal, MD
Advertisement
Ajay K. Gopal, MD, is a medical oncologist who specializes in lymphomas and other cancers of the blood and serves as the director of clinical research for hematology malignancies at Fred Hutch.
Articles by Ajay K. Gopal, MD
Ajay K. Gopal, MD, discusses the rationale for treating a 69-year-old woman with high-risk follicular lymphoma with a PI3-kinase inhibitor in the third-line setting.
Advertisement
Latest Updated Articles
Diagnosis of a 69-Year-Old Woman With Follicular LymphomaPublished: May 28th 2020 | Updated:
Treating R/R Follicular Lymphoma With PI3K InhibitorsPublished: May 28th 2020 | Updated:
Novel Therapies for Patients With Follicular LymphomaPublished: May 28th 2020 | Updated:
Maintenance Therapy for Follicular LymphomaPublished: May 28th 2020 | Updated:
Follicular Lymphoma: Treating Early ProgressionPublished: May 28th 2020 | Updated:
Follicular Lymphoma: Prognostic Scoring and Treatment DecisionsPublished: May 28th 2020 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Illuminating the Sequence of Third-Line Therapies in Metastatic CRC
5